Prevalence and risk factors for human immunodeficiency virus–associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort

References

• American Academy of Neurology. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type1 (HIV-1) infection: report of a Woking Group of the American Accademy of Neurol AIDS task Force. Neurology 1991; 41: 778–785
   PubMed Web of Science ®Google Scholar
• Becker J T, Lopez O L, Dew M A, Aizenstein H J. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS 2004; 18(Suppl 1)S11–S18, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Brew B J. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 2004; 18(Suppl 1)S75–S78, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• D'Arminio Monforte A, Cinque P, Mocroft A, Goebel F D, Antunes F, Katlama C, Stenz Justesen U, Vella S, Kirk O, Lundgren J. Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol 2004; 55: 320–328, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dore G J, Correll P K, Li Y, Kaldor J M, Cooper D A, Brew B J. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999; 13: 1249–1253, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dore G J, McDonald A, Li Y, Kaldor J M, Brew B J. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003; 17: 1539–1545, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ferrando S, Van Gorp W, McElhiney M, Goggin K, Sewell M, Rabkin J. Highly active antiretroviral treatment in HIV infection: benefits of neuropsychological function. AIDS 1998; 12: F65–F70, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Web of Science ®Google Scholar
• Forton D M, Thomas H C, Murphy C A, Allsop J M, Foster G R, Main J, Wesnes K A, Taylor-Robinson S D. Hepati-tis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35: 433–439, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hilsabeck R C, Perry W, Hassanein T I. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002; 35: 440–446, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Justice A C, McGinnis K A, Atkinson J H, Heaton R K, Young C, Sadek J, Madenwald T, Becker J T, Conigliaro J, Brown S T, Rimland D, Crystal S, Simberkoff M, Veterans Aging Cohort 5-Site Study Project Team. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study. AIDS 2004; 18(Suppl 1)S49–S59, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Letendre S, Cherner M, Ellis R, Marcotte T, Heaton R, McCutchan J A, Grant I, Individuals coinfected with hepatitis C (HCV) and HIV are more cognitively impaired than those with either virus alone. J NeuroVirol 2002; 8(Suppl 1)27–28, [CSA]
   PubMedGoogle Scholar
• Lezak M D. Neuropsychological assessment. Oxford University Press, New York 1983
   Google Scholar
• Mack K A, Ory M G. AIDS and older Americans at the end of the Twentieth Century. J Acquir Immune Defic Syndr 2003; 33(Suppl 2)S68–S75, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Masliah E, De Teresa R M, Mallory R E, Hansen L A. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 2000; 14: 69–74, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Navia B A, Price R W. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol 1987; 44: 65–69, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Neuenburg J K, Brodt H R, Herndier B G, Bickel M, Bacchetti P, Price R W, Grant R M, Schlote W. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31: 171–177, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ryan E L, Morgello S, Isaacs K, Naseer M, Gerits P, The Manhattan HIV Brain Bank. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 2004; 62: 957–962, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sacktor N, Lyles R H, Skolasky R, Kleeberger C, Selnes O A, Miller E N, Becker J T, Cohen B, McArthur J C, Multicenter AIDS Cohort Study. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology 2001; 56: 257–260, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Sacktor N, McDermott M P, Marder K, Schifitto G, Selnes O A, McArthur J C, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida J A, Cohen B, Epstein L. HIV-associated cognitive impairment before and after the advent of combination therapy. J NeuroVirol 2002; 8: 136–142, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Sidtis J J, Gatsonis C, Price R W, Singer E J, Collier A C, Richman D D, Hirsch M S, Schaerf F W, Fischl M A, Kieburtz K, Simpson D, Koch A, Feinberg J, Dafni U, The AIDS Clinical Trial Group. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group. Ann Neurol 1993; 33: 343–349, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Spinnler H, Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 1987; 6(Suppl 8)49–54
   Google Scholar
• Tozzi V, Balestra P, Galgani S, Murri R, Bellagamba R, Narciso P, Antinori A, Giulianelli M, Tosi G, Costa M, Sampaolesi A, Fantoni M, Noto P, Ippolito G, Wu A W. Neurocognitive performance and quality of life in patients with HIV infection. AIDS Res Hum Retrovirus 2003; 19: 643–652, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tozzi V, Balestra P, Galgani S, Narciso P, Sampaolesi A, Antinori A, Giulianelli M, Serraino D, Ippolito G. Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. JAIDS 2001; 28: 19–27, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar